These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 187407

  • 1. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats.
    Campbell WB, Schmitz JM, Itskovitz HD.
    Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407
    [Abstract] [Full Text] [Related]

  • 2. Pressor and stereoidogenic actions of [des-Asp1]angiotensin I dependency on conversion to angiotensin III.
    Vaughan ED, Peach MJ, Ackerly JA, Tsai BS, Larner A.
    Circ Res; 1977 May; 40(5 Suppl 1):I94-7. PubMed ID: 858177
    [Abstract] [Full Text] [Related]

  • 3. Biological activity of des-Asp1-angiotensin I in man.
    Kono T, Ikeda F, Oseko F, Imura H, Endo J.
    J Clin Endocrinol Metab; 1980 Jan; 50(1):40-5. PubMed ID: 7350186
    [Abstract] [Full Text] [Related]

  • 4. [des-Asp1]angiotensin II in the dog: blood levels and effect on aldosterone.
    Semple PF, Nicholls MG, Tree M, Fraser R.
    Endocrinology; 1978 Oct; 103(4):1476-82. PubMed ID: 744159
    [Abstract] [Full Text] [Related]

  • 5. Organ specificity of angiotensin II and Des-aspartyl angiotensin II in the conscious rat.
    Campbell WB, Pettinger WA.
    J Pharmacol Exp Ther; 1976 Aug; 198(2):450-6. PubMed ID: 948036
    [Abstract] [Full Text] [Related]

  • 6. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM, Vaughan ED, Peach MJ, Ayers CR.
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of corticosteroid biosynthesis by angiotensin I [des-asp1]angiotensin I, angiotensin II and [des-asp1]-angiotensin II in bovine adrenal fasciculata cells.
    Hepp R, Grillet C, Peytremann A, Vallotton MB.
    Endocrinology; 1977 Sep; 101(3):717-25. PubMed ID: 196831
    [Abstract] [Full Text] [Related]

  • 8. (7-Ile) angiotensin III: a relatively selective antagonist of angiotensin steroidogenesis.
    Campbell WB, Schmitz JM.
    Eur J Pharmacol; 1979 Mar 01; 54(3):209-16. PubMed ID: 218823
    [Abstract] [Full Text] [Related]

  • 9. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM, Ayers CR, Vaughan ED, Peach MJ, Herf SM.
    J Clin Invest; 1979 Apr 01; 63(4):718-26. PubMed ID: 438332
    [Abstract] [Full Text] [Related]

  • 10. Renal and adrenal responses to [des-Asp1]angiotensin I in the dog.
    Freeman RH, Davis JO, Khosla MC.
    Am J Physiol; 1978 Feb 01; 234(2):F130-4. PubMed ID: 623303
    [Abstract] [Full Text] [Related]

  • 11. Biological activity of des-Asp1-,Ileu8-angiotensin II (Ileu8-angiotensin III) in man.
    Kono T, Oseko F, Ikeda F, Nanno M, Endo J.
    J Clin Endocrinol Metab; 1976 Oct 01; 43(4):940-3. PubMed ID: 977730
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of angiotensin III action by DES-ASP1-,ILEU8-angiotensin II in man.
    Kono T, Ikeda F, Oseko F, Nanno M, Imura H, Endo J.
    Acta Endocrinol (Copenh); 1978 Feb 01; 87(2):359-66. PubMed ID: 580136
    [Abstract] [Full Text] [Related]

  • 13. Role of converting enzyme in the cardiovascular and adrenal cortical responses to (des-Asp1)-angiotensin I.
    Larner A, Vaughan ED, Tsai BS, Peach MJ.
    Proc Soc Exp Biol Med; 1976 Sep 01; 152(4):631-4. PubMed ID: 184474
    [Abstract] [Full Text] [Related]

  • 14. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JW.
    Brain Res; 1990 Apr 23; 514(1):5-10. PubMed ID: 2357530
    [Abstract] [Full Text] [Related]

  • 15. Vascular effects and metabolism of angiotensins and their metabolites in the isolated perfused rat kidney.
    Misumi J, Gonzales MF, Ogihara T, Corvol P, Ménard J.
    Clin Exp Hypertens A; 1983 Apr 23; 5(7-8):1151-62. PubMed ID: 6357560
    [Abstract] [Full Text] [Related]

  • 16. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.
    Campbell WB, Gomez-Sanchez CE, Adams BV, Schmitz JM, Itskovitz HD.
    J Clin Invest; 1979 Dec 23; 64(6):1552-7. PubMed ID: 500824
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin antagonists with increased specificity for the renal vasculature.
    Taub KJ, Caldicott WJ, Hollenberg NK.
    J Clin Invest; 1977 Mar 23; 59(3):528-35. PubMed ID: 190270
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of angiotensin I converting enzyme inhibition by SQ20,881 (less than Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo. Further evidence for extrapulmonary conversion.
    Oparil S, Koerner T, O'Donoghue JK.
    Hypertension; 1979 Mar 23; 1(1):13-22. PubMed ID: 232489
    [Abstract] [Full Text] [Related]

  • 19. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II.
    Hepp R, Grillet C, Peytremann A, Vallotton MB.
    Prog Biochem Pharmacol; 1976 Mar 23; 12():41-8. PubMed ID: 1019169
    [Abstract] [Full Text] [Related]

  • 20. Effect of a heptapeptide angiotensin analog on aldosterone secretion in the rabbit.
    Neusy AJ, Pessah M, Steele JM, Lowenstein J.
    Kidney Int; 1980 Jan 23; 17(1):66-73. PubMed ID: 6990089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.